🔗 Share this article

A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors market the drug there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, advertising, and customer laws, risking penalties, prosecution or prison.

Service Reaction and Material Removal

According to the social media company, the service has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, glowing reviews and detailed instructions for mixing or administering at home.

After minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, medical conditions or previous experience.

Product Information and Costs

Within these communities, posts display black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has already seen patients injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly serious medical dangers”.